Teriflunomide

CHEMBL973 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
270.2 g/mol
LogP
3.3
Phase
4

This oral medication is used to reduce the frequency of relapses and slow the progression of relapsing forms of multiple sclerosis (MS). It works by blocking an enzyme needed for the production of immune cells that attack the myelin sheath around nerves. Women of childbearing age must use reliable contraception during treatment due to the risk of serious birth defects.

Peso molecular

270,2100 g/mol

LogP

3,30

TPSA

73,10 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1

InChI

InChI=1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-

Molecular Formula

C12H9F3N2O2

HBD / HBA

2 / 6

Enlaces Rotables

2

Átomos Pesados

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This oral medication is used to reduce the frequency of relapses and slow the progression of relapsing forms of multiple sclerosis (MS). It works by blocking an enzyme needed for the production of immune cells that attack the myelin sheath around nerves. Women of childbearing age must use reliable contraception during treatment due to the risk of serious birth defects.

Yes, Teriflunomide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL973. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 54684141. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.